Skip to main content
Clinical Trials/NCT01708382
NCT01708382
Completed
Not Applicable

Feasibility Study: Evaluation of the Ulthera® System for Lifting and Tightening of the Elbow Tissue - A Feasibility Study

Ulthera, Inc1 site in 1 country21 target enrollmentSeptember 2011
ConditionsSkin Laxity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Skin Laxity
Sponsor
Ulthera, Inc
Enrollment
21
Locations
1
Primary Endpoint
Overall improvement of skin laxity in the areas treated
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Up to 20 subjects will be treated. Treated subjects will receive one Ulthera® treatment on the elbows. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.

Detailed Description

This is a prospective, single-center, pilot clinical trial to evaluate the efficacy of the Ulthera® System to improve skin laxity above the elbows. Masked assessment of pre- and post-treatment photos will be performed. Global Aesthetic Improvement Scale scores and patient satisfaction questionnaires will also be obtained.

Registry
clinicaltrials.gov
Start Date
September 2011
End Date
February 2013
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female, age 21 to 65 years.
  • Subject in good health.
  • Mild to moderate skin laxity on the elbows.
  • Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period.
  • Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study.
  • Subjects of childbearing potential must have a negative urine pregnancy test result and must not be lactating at Visit 1 and be willing and able to use an acceptable method of birth control

Exclusion Criteria

  • Presence of an active systemic or local skin disease that may affect wound healing.
  • Excessive subcutaneous fat around the elbows.
  • Excessive skin laxity around the elbows.
  • Significant scarring in areas to be treated.
  • Significant open wounds or lesions in the area to be treated

Outcomes

Primary Outcomes

Overall improvement of skin laxity in the areas treated

Time Frame: 90 days post-treatment

Determined by masked assessment analysis of photographs at 90 days post treatment compared to baseline.

Secondary Outcomes

  • Aesthetic improvement(90 and 180 days post-treatment)

Study Sites (1)

Loading locations...

Similar Trials